OM Pharma Overview
- Founded
-
1937

- Status
-
Acquired/Merged
- Employees
-
400

- Latest Deal Type
-
M&A
- Financing Rounds
-
2
OM Pharma General Information
Description
Manufacturer of pharmaceuticals in Geneva, Switzerland. The company offers a diversified portfolio of prescription medicines as well as over-the-counter (OTC) products. It specializes in the research, manufacturing and sale of biotechnological and synthetic drugs.
Contact Information
Website
www.ompharma.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Office
- Rue du Bois-du-Lan 22
- Meyrin 2
- 1217 Geneva
- Switzerland
+41 022 000 00 00
OM Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
OM Pharma Patents
OM Pharma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2021236256-A1 | Novel hydroquinone derivaties | Pending | 11-Mar-2020 | 0000000000 | |
CA-3165209-A1 | 2,5- or 2,6-disubstituted hydroquinone derivatives with at least one carboxy, sulfo or amido group useful as medicaments | Pending | 11-Mar-2020 | 0000000000 | |
EP-3878837-A1 | 2,5- or 2,6-disubstituted hydroquinone derivatives with at least one carboxy, sulfo or amido group useful as medicaments | Inactive | 11-Mar-2020 | 0000000000 | 0 |
EP-4118069-A1 | 2,5- or 2,6-disubstituted hydroquinone derivatives with at least one carboxy, sulfo or amido group useful as medicaments | Pending | 11-Mar-2020 | 0000000000 | |
JP-2023517693-A | New hydroquinone derivative | Pending | 11-Mar-2020 | C07D251/20 |
OM Pharma Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Josef Troxler Ph.D | President | ||
Laurent Perritaz | Head of Finance |
OM Pharma Signals
OM Pharma Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|